{"disease":{"id":"gallbladder-cancer","name":"gallbladder cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06223061","title":"Global Evaluation of Cholecystectomy Knowledge and Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":53708,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT06192719","title":"EULAT Eradicate GBC","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Centre Paul Strauss","has_results":false},{"nct_id":"NCT06276153","title":"Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT02692911","title":"Chile Biliary Longitudinal Study","phase":"","overall_status":"COMPLETED","enrollment_count":4749,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04637048","title":"Observational Study on Patients With Hepatobiliary Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Gang Chen, MD","has_results":false},{"nct_id":"NCT03637569","title":"The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT06061744","title":"Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Hospital del Mar","has_results":false},{"nct_id":"NCT05489250","title":"The PLATON Network","phase":"","overall_status":"TERMINATED","enrollment_count":565,"lead_sponsor_name":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","has_results":false},{"nct_id":"NCT05896956","title":"The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05184400","title":"Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT03768414","title":"Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT04445532","title":"Hepatobiliary Tumors Tissue Samples Acquisition","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04484636","title":"PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","has_results":false},{"nct_id":"NCT04907643","title":"Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT04534309","title":"Behavioral Weight Loss Program for Cancer Survivors in Maryland","phase":"NA","overall_status":"COMPLETED","enrollment_count":340,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT04066491","title":"Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":309,"lead_sponsor_name":"EMD Serono Research & Development Institute, Inc.","has_results":true},{"nct_id":"NCT07092397","title":"Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":266,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07007832","title":"Bile Omics for Diagnosing Indeterminate Biliary Strictures","phase":"","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04742959","title":"Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"TransThera Sciences (Nanjing), Inc.","has_results":false},{"nct_id":"NCT03491878","title":"Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04559139","title":"Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":186,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT03833661","title":"M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"EMD Serono Research & Development Institute, Inc.","has_results":true},{"nct_id":"NCT05596370","title":"Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06789224","title":"Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device","phase":"NA","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"Lindis Bloodcare GmbH","has_results":false},{"nct_id":"NCT04871321","title":"Biomarker Discovery in Patients With Advanced Biliary Tract Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"CHA University","has_results":false},{"nct_id":"NCT06717464","title":"Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT04068194","title":"Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":103,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05404347","title":"NGS in Gallbladder Cancer and Response to Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Banaras Hindu University","has_results":false},{"nct_id":"NCT04337333","title":"Two-in-one Covered and Uncovered Metal Stent","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Ajou University School of Medicine","has_results":false},{"nct_id":"NCT05253053","title":"To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"TransThera Sciences (Nanjing), Inc.","has_results":false},{"nct_id":"NCT05718115","title":"Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT03673072","title":"Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Krankenhaus Nordwest","has_results":false},{"nct_id":"NCT05564403","title":"Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":66,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02392637","title":"Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT02495896","title":"Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02520141","title":"Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT05620498","title":"Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT04941287","title":"Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05833815","title":"Addition of Everolimus to Standard of Care in Carcinoma Gallbladder","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Banaras Hindu University","has_results":false},{"nct_id":"NCT03257761","title":"Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":55,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT04383210","title":"Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"Elevation Oncology","has_results":true},{"nct_id":"NCT05757336","title":"Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Lu Wang, MD, PhD","has_results":false},{"nct_id":"NCT03260712","title":"Pembrolizumab in Biliary Tract Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT06901622","title":"Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Zhengzhou University","has_results":false},{"nct_id":"NCT00486356","title":"Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"University of Nebraska","has_results":false},{"nct_id":"NCT04308174","title":"Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT07310069","title":"Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":44,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06963060","title":"Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":44,"lead_sponsor_name":"Wei Gong","has_results":false},{"nct_id":"NCT06423170","title":"A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06189664","title":"Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Imperial College London","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}